NHS health checks through general practice: randomised trial of population cardiovascular risk reduction

BMC Public Health

Yvonne Mawby¹  Ruth Chambers¹  Jagdish Kumar¹  Christopher Gidlow³  Zafar Iqbal¹  Rachel Davey²  Thomas Cochrane² 

[1]NHS Stoke on Trent, Directorate Public Health, Civic Centre, Glebe Street, Stoke on Trent, ST4 1HH, United Kingdom

[2]Centre for Research and Action in Public Health, Faculty of Health, University of Canberra, Canberra ACT2601, Australia

[3]Centre for Sport, Health and Exercise Research, Staffordshire University, Leek Road Campus, Stoke on Trent, ST4 2DF, United Kingdom

关键词: Policy implementation;    Multi-factorial risk;    Prevention;    Lifestyle change;    Vascular disease;   

Others  :  1162886
DOI  :  10.1186/1471-2458-12-944

 received in 2012-08-06, accepted in 2012-10-15,  发布年份 2012

【 摘 要 】

Background

The global burden of the major vascular diseases is projected to rise and to remain the dominant non-communicable disease cluster well into the twenty first century. The Department of Health in England has developed the NHS Health Check service as a policy initiative to reduce population vascular disease risk. The aims of this study were to monitor population changes in cardiovascular disease (CVD) risk factors over the first year of the new service and to assess the value of tailored lifestyle support, including motivational interview with ongoing support and referral to other services.

Methods

Randomised trial comparing NHS Health Check service only with NHS Health Check service plus additional lifestyle support in Stoke on Trent, England. Thirty eight general practices and 601 (365 usual care, 236 additional lifestyle support) patients were recruited and randomised independently between September 2009 and February 2010. Changes in population CVD risk between baseline and one year follow-up were compared, using intention-to-treat analysis. The primary outcome was the Framingham 10 year CVD risk score. Secondary outcomes included individual modifiable risk measures and prevalence of individual risk categories. Additional lifestyle support included referral to a lifestyle coach and free sessions as needed for: weight management, physical activity, cook and eat and positive thinking.

Results

Average population CVD risk decreased from 32.9% to 29.4% (p <0.001) in the NHS Health Check only group and from 31.9% to 29.2% (p <0.001) in the NHS Health Check plus additional lifestyle support group. There was no significant difference between the two groups at either measurement point. Prevalence of high blood pressure, high cholesterol and smoking were reduced significantly (p <0.01) in both groups. Prevalence of central obesity was reduced significantly (p <0.01) in the group receiving additional lifestyle support but not in the NHS Health Check only group.

Conclusions

The NHS Health Check service in Stoke on Trent resulted in significant reduction in estimated population CVD risk. There was no evidence of further benefit of the additional lifestyle support services in terms of absolute CVD risk reduction.

【 授权许可】

   
2012 Cochrane et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T: Trends and disparities in coronary heart disease, stroke and other cardiovascular diseases in the United States. Findings of the National Conference on Cardiovascular Disease Prevention. Circulation 2000, 102:3137-3147.
• [2]Murray CJL, Lopez A: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
• [3]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
• [4]Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004, 291:2616-2622.
• [5]Wright IS, Frederickson DT (Eds): Cardiovascular Diseases: Guidelines for Prevention and Care. Reports of the Intersociety Commission for Heart Disease Resources. Washington, DC: US Government Printing Office; 1973.
• [6]American Heart Association: A Public Health Action Plan to Prevent Heart Disease and Stroke. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2010.
• [7]Halpin HA, Morales-Suárez-Varela MM, Martin-Moreno JM: Chronic disease prevention and the New Public Health. Public Health Rev 2010, 32:120-154.
• [8]Department of Health: Putting Prevention First, Vascular Check: Risk Assessment and Management. London: Department of Health; 2008.
• [9]Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin P-H, Aickin M, Most-Windhauser MM, Moore TJ, Proschan MA, Cutler JA, for the DASH–Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. New Engl J Med 2001, 344:3-10.
• [10]Knowler WC, Barrett-Connor E, Fowler SE, Richard F, Hamman RF, Lachin JM, Walker EA, Nathan DM, for the Diabetes Prevention Program Research Group the Diabetes Prevention Program Research Group: Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002, 346:393-403.
• [11]Capewell S, Ford ES: Why have total cholesterol levels declined in most developed countries? BMC Publ Health 2011, 11:641. BioMed Central Full Text
• [12]Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet 2005, 365:434-441.
• [13]Anderson KM, Odell PM, Wilson PWF, Kannel WB: Cardiovascular disease risk profiles. Am Heart J 1990, 121:293-298.
• [14]Benner JS, Erhardt L, Benner FMJS, Erhardt L, Flammer M, Moller RA, Rajicic N, Changela K, Yunis C, Cherry SB, Gaciong Z, Johnson ES, Sturkenboom MCJM, García-Puig J, Girerd X: A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients’ modifiable risk factor profile. Int J Clin Pract 2008, 82:1484-1498.
• [15]Maruthur NM, Wang N-Y, Appel LJ: Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation 2009, 119:2026-2031.
• [16]Brett T, Arnold-Reed D, Phan C, Frances Cadden F, Walker W, Manea-Walley W, Mora N, Young J, Bulsara M: The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction. Br J Gen Pract 2012, 62(594):e22-e28.
• [17]Davey R, Cochrane T, Iqbal Z, Rajaratnam G, Chambers R, Mawby Y, Picariello L, Leese C, Ryder N: Randomised controlled trial of additional lifestyle support for the reduction of cardiovascular disease risk through primary care in Stoke-on-Trent, UK. Contemp Clin Trials 2010, 31:345-354.
• [18]NHS Stoke on Trent: Primary Prevention Toolkit. Available at: http://www.stokepct.nhs.uk/pdfs/936.pdf webcite
• [19]Joint British Societies: JBS2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91(5):v1-v52.
• [20]Department of Health: General practice physical activity questionnaire. Available at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_063813.pdf webcite
• [21]Raudenbush SW: Statistical analysis and optimal design for cluster randomised trials. Psychol Methods 1997, 2:173-185.
• [22]Tabenkin H, Eaton CB, Roberts MB, Parker DR, McMurray JH, Borkan J: Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient. Ann Fam Med 2010, 8:25-32.
• [23]Priebe H-J: The aged cardiovascular risk patient. Brit J Anaesth 2000, 85:763-778.
• [24]Nilsson PM, Boutouyrie P, Laurent S: Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009, 54:3-10.
• [25]Department of Communities and Local Government: The English Indices of Deprivation 2010. Her Majesty’s Stationery Office; March 2011. GP Practice IMD 2010 scores were provided by the West Midlands Public Health Observatory on behalf of the Department of Health. Birmingham: West Midlands Public Health Observatory; 2012.
• [26]Kumar J, Mawby Y, Chambers R, Leese C, Iqbal Z: Implementing the NHS Health Check in general practice. Nurs Pract 2011, 59:10-12.
• [27]Kumar J, Mawby Y, Chambers R, Leese C, Iqbal Z, Picariello L, Richardson D: Delivering more with less? Making the NHS Health Check work in financially hard times: real time learning from Stoke-on-Trent. Qual Prim Care 2011, 19:193-199.
• [28]Blumenthal D: Performance improvement in health care – seizing the moment. New Engl J Med 2012, 366:1953-1955. Published 25 April 2012 at NEJM.org
• [29]Donders ART, van der Heijdenc GJMG, Stijnend T, Moons KGM: Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 2006, 59:1087-1091.
• [30]Azur MJ, Stuart EA, Frangakakis C, Leaf PJ: Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res 2011, 20(1):40-49.